On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats

British Journal of Pharmacology

Volumn 129, Issue 3, 2000, Pages 582-588

  Miele, Maddalena ^a   Mura, Maria A ^a   Enrico, Paolo ^a   Esposito, Giovanni ^a   Serra, Pier A ^a   Migheli, Rossana ^a   Zangani, Danilo ^a   Miele, Egidio ^a   Desole, Maria S ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Ascorbic acid; d amphetamine; Glutamate aspartate; Microdialysis; Rat striatum; Uric acid

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ASPARTIC ACID; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMIC ACID; HOMOVANILLIC ACID; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINE RELEASE; DRUG MECHANISM; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ASCORBIC ACID; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; GLUTAMIC ACID; HALOPERIDOL; INJECTIONS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NEOSTRIATUM; OXIDATION-REDUCTION; RATS; RATS, WISTAR; STEREOTAXIC TECHNIQUES; STEREOTYPED BEHAVIOR; URIC ACID;

EID: 0033982544     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703066     Document Type: Article

References (40)

1. BASSE‐TOMUSK, A. & REBEC, C.V. (1990). Corticostriatal and thalamic regulation of amphetamine‐induced ascorbate release in neostriatum. Pharmacol. Biochem. Behav., 35, 55–60.
2. BIGGS, C.S., FOWLER, L.J., WHITTON, P.S. & STARR, M.S. (1997). Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by micro‐dialysis: regulation by striatal dopamine D 2 receptors via the indirect striatal output pathway Brain Res., 753, 163–175.
3. CADONI, C., PINNA, A., RUSSI, G., CONSOLO, G. & DI CHIARA, G. (1995). Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunochemistry. Neuroscience, 65, 1027–1039.
4. CAMMACK, J., GHASEMZADEH, B. & ADAMS, R.N. (1991). The pharmacological profile of glutamate‐evoked ascorbate efflux measured by in vivo electrochemistry. Brain Res., 565, 17–22.
5. CHIUEH, C.C. (1994). Auto‐oxidation of dopamine and formation of free radicals in vivo. In: Louilot, A., Durkin, A.T., Spampinato, U. & Cador, M. (eds.). Monitoring Molecules in Neuroscience. Universities of Bordeaux I & II. pp. 127–128.
6. CHURCH, W.H. & WARD, V.L. (1994). Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine autoxidation. Brain Res. Bull., 33, 419–425.
7. DESOLE, M.S., ANANIA, V., ESPOSITO, G., CARBONI, F., SENINI, A. & MIELE, E. (1987). Neurochemical and behavioural changes induced by ascorbic acid and d‐amphetamine in the rat. Pharmacol. Res. Comm., 19, 441–450.
8. DESOLE, M.S., MIELE, M., ENRICO, P., FRESU, L., ESPOSITO, G., DE NATALE, G. & MIELE, E. (1992). The effects of cortical ablation on d‐amphetamine‐induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat. Neurosci. Lett., 139, 29–33.
9. ENRICO, P., ESPOSITO, G., MURA, M.A., MIGHELI, R., SERRA, P.A., DESOLE, M.S., MIELE, E., DE NATALE, G. & MIELE, M. (1997). Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies. Pharmacol. Res., 35, 577–585.
10. HERRERA‐MARSCHITZ, M., YOU, Z.B., GOINY, M., MEANA, J.J., SILVEIR, R., GODUKIN, O.V., ESPINOZA, S., PETTERSON, E., LOIDL, C.F., LUBEC, G., ANDERSONN, K., NYLANDER, I., TERENIUS, L. & UNGERSTEDT, U. (1996). On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J. Neurochem., 66, 1726–1735.
11. JONES, S.R., GAINETDINOV, R.R., WINGTHMAN, R.M. & CARON, M.G. (1998). Mechanism of amphetamine action as revealed in mice lacking the dopamine transporter. J. Neurosci., 18, 1979–1986.
12. KARLER, K., CALDER, L.D., THAI, L.H. & BEDINGFIELD, J.B. (1995). The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine. Brain. Res., 671, 100–104.
13. LABARCA, R., GAJARDO, M.I., SEGUEL, M., SILVA, H., JEREZ, S., RUIZ, A. & BUSTOS, G. (1995). Effects of d‐amphetamine administration on the release of endogenous excitatory amino acids in the rat nucleus accumbens. Progr, Neuropsychoph., 19, 467–473.
14. MAJEWSKA, M.D., BELL, J.A. & LONDON, E.D. (1990). Regulation of NMDA receptor by redox phenomena:inhibitory role of ascorbate. Brain Res., 537, 328–332.
15. MENNERICK, S., BENZ, A. & ZORUMSLY, C.F. (1996). Components of glial response to exogenous and synaptic glutamate in rat hippocampal microcultures. J. Neurosci., 16, 55–64.
16. MIELE, M., BOUTELLE, M.G. & FILLENZ, M. (1994). The physiologically‐induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake. Neuroscience, 62, 87–91.
17. MIELE, M. & FILLENZ, M. (1996). In vivo determination of extracellular brain ascorbate. J. Neurosci. Meth., 70, 15–19.
18. MORARI, M., MARTI, M., SBRENNA, S., FUXE, K., BIANCHI, C. & BEANI, L. (1998). Reciprocal dopamine‐glutamate modulation of release in basal ganglia. Neurochem. Int., 33, 383–397.
19. MORTON, D.B. & GRIFFITHS, P.H.M. (1985). Guidelines on the recognition of pain, distress and discomfort in experimental animals and a hypothesis for assessment. Vet. Records, 116, 431–436.
20. MUELLER, K. & KUNKO, P.M. (1990). The effects of amphetamine and pilocarpine on the release of ascorbic acid and uric acid in several rat brain areas. Pharmacol. Biochem. Behav., 35, 871–876.
21. OHMORI, T., ABEKAWA, T. & KOYAMA, T. (1996). The role of glutamate in the behavioral effects of methamphetamine. Neurochem. Int., 29, 301–307.
22. O'NEILL, R.D. (1995). The measurement of brain ascorbate in vivo and its link with excitatory amino acid neurotransmission. In: Boulton, A., Baker, G. & Adams, R.N. (eds.). Neurometods, Vol. 27 Voltammetric Methods in Brain Systems. Humana Press Inc. pp. 221–268.
23. O'NEILL, R.D., FILLENZ, M., SUNDSTROM, L. & RAWLINS, J.N.P. (1984). Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrstrained rat. Neurosci. Lett., 52, 227–233.
24. PAXINOS, G. & WATSON, C. (1986). Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
25. PIERCE, R.C., CLEMENT, J.A., GRABNER, C.P. & REBEC, G.V. (1994). Amphetamine promotes neostriatal ascorbate release via a nigro‐talamo‐cortico‐neostriatal loop. J. Neurochem., 63, 1499–1507.
26. REBEC, G.V., CENTORE, J.M., WHITE, L.K. & ALLOWAY, K.D. (1985). Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs. Science, 227, 438–440.
27. REBEC, G.V. & PIERCE, C.P. (1994). A vitamin as neuro‐modulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Progr. Neurobiol., 43, 537–565.
28. REID, M.S., HSU JR K. & BERGER, S.P. (1997). Cocaine and amphetamine preferentially stimulate glutamate release in limbic system: studies on the involvement of dopamin. Synapse, 27, 95–105.
29. ROBERTSON, G.S., DAMSMA, G. & FIBIGER, H.C. (1991). Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci., 11, 2209–2216.
30. ROBINSON, T.E. & BECKER, J.B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev., 11, 1067–1079.
31. SAPONJIC, R.M., MUELLER, K., KRUG, D. & KUNKO, P.M. (1994). The effects of haloperidol, scopolamine, and MK‐801 on amphetamine‐induced increase in ascorbic acid and uric acid as determined by voltammetry in vivo. Pharmacol. Biochem. Behav., 48, 161–168.
32. SEVANIAN, A., DAVIES, K.J.A. & HOCHSTEIN, P. (1991). Serum urate as an antioxidant for ascorbic acid. Am. J. Clin. Nutr., 54, 129S–134S.
33. SULZER, D., CHEN, T‐K., LAU, Y.Y., KRISTENSEN, H., RAYPORT, S. & EWING, A. (1995). Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci., 15, 4102–4108.
34. WAN, R.Q., GIOVANNI, A., KAFKA, S.H. & CORBETT, R. (1996). Neonatal ippocampal lesions‐induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav. Brain. Res., 78, 211–223.
35. WESTERINK, B.H.C., DE BOER, P., SANTIAGO, M. & DE VRIES, J.B. (1994). Do nerve terminals and cell bodies of nigrostriatal dopaminergic neurons of the rat contain similar receptors Neurosci. Lett., 167, 109–112.
36. WHITE, L.K., MAURER, M.A., SIDELL, E.A., KRAFT, M.E., OH, C. & REBEC, G.V. (1990). Intrastriatal infusion of ascorbate antagonizes the behavioral response to amphetamine. Pharmacol. Biochem. Behav., 36, 485–489.
37. WILSON, R.L. & WINGTHMAN, R.M. (1985). Systemic and nigral application of amphetamine both cause an increase of extracellular concentrations of ascorbate in the caudate nucleus of the rat. Brain Res., 370, 219–226.
38. YAMAMOTO, B.K. & DAVY, M. (1992). Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem., 58, 1736–1742.
39. ZETTERSTRÖM, T. & FILLENZ, M. (1988). Changes in striatal dopamine, ascorbic acid and motor activity in rats after administration of dopamine receptor agonists. Brit. J. Pharmacol., 93, p. 49.
40. ZETTERSTRÖM, T., SHARO, T. & UNGERSTEDT, U. (1986). Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur. J. Pharmacol., 132, 1–9.